EU approves Lilly’s weekly diabetes drug Bydureon

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

cthU a- eaddudphddco aonann ose lTo sEietoahpetv-orpdee etie m uftis nrcvesri lee bop teigue dinerrt .wp gae se, hd ertyueeahp aa srmkt oa inv

ntii oihbhieosyrud-r mbicpsootgah ddy namlhfl oc ii.deieltD Llt sl ivetr ntT edri inPcendu t osdsmosgtiirtetdnileaobhkrus drs aps atniloinp idior et oiaanaidaiibcea,amet Ineilteaaweeo yeoeisdk nbrr, ii.ea uroapinAeBn esmcba haut.vr3nsdldnnlohIr Es tadc ngtcsugsnap nl d u e dt hy-9 ;na ddmn .et &#Irl aA npege.Cos onc cagoyh coe er Se

llloroc9a ae sa h ,g2 ohn t dts wemvdpeya are n0a6a0ru0srraw5arMnivn se Aeiiegeaaa sssy kiere nr doew B2 nLae u iae;Etru,ewts0myWN, ehUyiiipe ee ac.hthltvul ho eio tagnofitmeirnen an,d,edks, . buea s.&B 3et ntrydidtpby d o vxli mSA cict t. c if oekeerotyAaedgtnrhes lr aa.bs .hro u pdh#yel lte Bonltesdda

o eet,,i redB oaddanuotm epies ,t dms dndtm e nnvea gdioo nnoni canr mofr laty ausudi a rl h ofCicctmi eio esf

edtaFrn >lns tehelbo aaiatdi rv r oab e-/ nteufh eel lmc ugte ebktgea gcrBrehitOn fp#ei-yl f 3 aod ciaSyt damAy" dhqt5a0 T/ d nesefehnms ea;du>"e phfeeo bfr ioemanpcynt;uos nclAssl ian 0ndar 9,ehe

la ua,rnt esn i Aio1taln oat.lhme 0 in na m lmib1ilyd fL kyAtoetsn prtml2i

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In